Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum

Lancet

Volumn 360, Issue 9333, 2002, Pages 610-617

  Pombo, David J ^a,b   Lawrence, Gregor ^a   Hirunpetcharat, Chakrit ^c   Rzepczyk, Christine ^a   Bryden, Michelle ^a   Cloonan, Nicole ^a   Anderson, Karen ^a   Mahakunkijcharoen, Yuvadee ^d   Martin, Laura B ^a   Wilson, Danny ^a   Elliott, Salenna ^a   Elliott, Suzanne ^a   Eisen, Damon P ^a   Weinberg, J Brice ^e   Saul, Allan ^a   Good, Michael F ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF UTAH   (United States)

^c CHIANG MAI UNIVERSITY   (Thailand)

^d MAHIDOL UNIVERSITY   (Thailand)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CYTOKINE; DNA; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; NITRIC OXIDE SYNTHASE; PARASITE ANTIGEN;

ANTIBODY DETECTION; ANTIBODY SCREENING; ARTICLE; BLOOD ANALYSIS; CELL COUNT; CELL PROLIFERATION; CELLULAR IMMUNITY; CRYOPRESERVATION; CYTOKINE PRODUCTION; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME INDUCTION; ERYTHROCYTE; EXPOSURE; FEMALE; FOLLOW UP; GENETIC ANALYSIS; HUMAN; IMMUNE RESPONSE; INOCULATION; MALARIA; MALE; MEROZOITE; MONONUCLEAR CELL; NATURAL KILLER CELL; NORMAL HUMAN; PARASITE PREVALENCE; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHIZONT; SYMPTOMATOLOGY; T LYMPHOCYTE;

EID: 0037167246     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)09784-2     Document Type: Article

References (32)

1. Marsh K., Howard R.J. Antigens induced on erythrocytes by P falciparum: expression of diverse and conserved determinants. Science. 231:1986;150-153.
2. Bull P.C., Lowe B.S., Kortok M., Molyneux C.S., Newbold C.I., Marsh K. Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria. Nat Med. 4:1988;358-360.
3. Newbold C.I. Antigenic variation in Plasmodium falciparum: mechanisms and consequences. Curr Opin Microbiol. 2:1999;420-425.
4. Piper K.P., Hayward R.E., Cox M.J., Day K.P. Malaria transmission and naturally acquired immunity to PfEMP-1. Infect Immun. 67:1999;6369-6374.
5. Bull P.C., Lowe B.S., Kortok M., Marsh K. Antibody recognition of Plasmodium falciparum erythrocyte surface antigens in Kenya: evidence for rare and prevalent variants. Infect Immun. 67:1999;733-739.
6. 19) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells. J Immunol. 159:1997;3400-3411.
7. Amante F.H., Good M.F. Prolonged Th1-like response generated by a Plasmodium yoelii-specific T cell clone allows complete clearance of infection in reconstituted mice. Parasite Immunol. 19:1997;111-126.
8. Taylor-Robinson A.W., Phillips R.S., Severn A., Moncada S., Liew F.Y. The role of TH1 and TH2 cells in a rodent malaria infection. Science. 260:1993;1931-1934.
9. + T cells from non-exposed donors. Parasite Immunol. 16:1994;579-586.
10. + T cells adoptively transferred into recipient mice after challenge with homologous parasite. Proc Natl Acad Sci USA. 95:1998;1715-1720.
11. Ho M., Webster H.K., Looareesuwan S., et al. Antigen-specific immunosuppression in human malaria due to Plasmodium falciparum. J Infect Dis. 153:1986;763-771.
12. Xu H., Wipasa J., Yan H., et al. The mechanism and significance of deletion of parasite-specific CD4+ T cells in malaria infection. J Exp Med. 195:2002;881-892.
13. Good M.F. Towards a blood-stage vaccine for malaria: are we following all the leads? Nature Rev Immunol. 1:2001;117-125.
14. Cheng Q., Lawrence G., Reed C., et al. Measurement of Plasmodium falciparum growth rates in vivo: a test of malaria vaccines. Am J Trop Med Hyg. 57:1997;495-500.
15. Coombs R.R., Mourant A.E., Race R.R. Br J Exp Pathol. 26:1945;255-266.
16. Staalsoe T., Giha H.A., Dodoo D., Theander T.G., Hviid L. Detection of antibodies to variant antigens on Plasmodium falciparum-infected erythrocytes by flow cytometry. Cytometry. 35:1999;329-336.
17. Anstey N.M., Weinberg J.B., Hassanali M.Y., et al. Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. J Exp Med. 184:1996;1-11.
18. Weinberg J.B., Misukonas M.A., Shami P.J., et al. Human mononuclear phagocyte inucible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages. Blood. 86:1995;1184-1195.
19. Currier J., Sattabongkot J., Rosenberg R., Good M.F. Natural' T cells responsive to malaria: evidence implicating immunological cross-reactivity in the maintenance of TCR alpha beta+ malaria-specific responses from non-exposed donors. Int Immunol. 4:1992;985-994.
20. Mohan K., Moulin P., Stevenson M.M. Natural killer cell cytokine production, not cytotoxicity, contributes to resistance against blood-stage Plasmodium chabaudi AS infection. J Immunol. 159:1997;4990-4998.
21. Seixas E.M., Langhorne J. γδ T cells contribute to control of chronic parasitemia in Plasmodium chabaudi infections in mice. J Immunol. 162:1999;2837-2841.
22. Luty A.J., Lell B., Schmidt-Ott R., et al. Interferon-gamma responses are associated with resistance to reinfection with Plasmodium falciparum in young African children. J Infect Dis. 179:1999;980-988.
23. Fang F.C. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest. 99:1997;2818-2825.
24. Gyan B., Troye-Blomberg M., Perlmann P., Bjorkman A. Human monocytes cultured with and without interferon-gamma inhibit Plasmodium falciparum in vitro via secretion of reactive nitrogen intermediates. Parasite Immunol. 16:1994;371-375.
25. Rockett K.A., Awburn M.M., Cowden W.B., Clark I.A. Killing of Plasmodium falciparum in vitro by nitric oxide derivatives. Infect Immun. 59:1991;3280-3283.
26. Thoma-Uszynski S., Stenger S., Takeuchi O., et al. Induction of direct antimicrobial activity through mammalian toll-like receptors. Science. 291:2001;1544-1547.
27. Godfrey D.I., Hammond K.J.L., Poulton L.D., Smyth M.J., Baxter A.G. NKT cells: facts, functions and fallacies. Immunol Today. 21:2000;573-583.
28. Marsh K., Otoo L., Hayes R.J., Carson D.C., Greenwood B.M. Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection. Trans R Soc Trop Med Hyg. 83:1989;293-303.
29. Butcher G.A. HIV and malaria: a lesson in immunology. Parasitol Today. 8:1992;307-311.
30. Whitworth J., Morgan D., Quigley M., et al. Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study. Lancet. 356:2000;1051-1056.
31. Parish C.R. The relationship between humoral and cell-mediated immunity. Transplant Rev. 13:1972;35-66.
32. Bretscher P.A., Wei G., Menon J.N., Bielefeldt-Ohmann H. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science. 257:1992;539-542.